Item # | 7001 |
Exp. Date | 1/26 |
Quantity | 30 single-use vials/box |
NDC | 83368-075-30 |
Other Information | Now in stock! |
New product
Special Introductory Pricing!
Warning: Last items in stock!
Estimated in stock: 03/28/2024
Ryzumvi™ 0.75% Dilation Reversal Drop
Special Introductory Pricing!
Recipient :
* Required fields
or Cancel
Re-imagine the post-dilation experience for your patients with the only FDA-approved product to rapidly reverse dilation.
Ryzumvi™ is an alpha adrenergic blocker indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents.
The onset of action after administration of Ryzumvi generally occurs in 30 minutes, with the maximal effect seen in 60 to 90 minutes.
According to RYZUMVI’s prescribing information (PI), the following dosages are advised:
Each box contains 30 single-use vials. There are approximately 8 drops in each vial.
For more information about Ryzumvi, we encourage you to view this product information brochure: RYZUMVI PRODUCT INFORMATION
This may take a few moments. Do not press the back button during this time.